IL10 and colitis: It was also reported in an experimental TNBS-colitis model in SJL/J mice that the transfer of Treg cells prevents the establishment of the disease and that this protective effect is abolished by the administration of anti-IL-10 and/or anti-TGF-β antibodies [92].